European Surgery-Acta Chirurgica Austriaca最新文献

{"title":"Coronavirus and surgery.","authors":"U A Khan, M A Gok","doi":"10.1007/s10353-020-00647-y","DOIUrl":"https://doi.org/10.1007/s10353-020-00647-y","url":null,"abstract":"","PeriodicalId":50475,"journal":{"name":"European Surgery-Acta Chirurgica Austriaca","volume":null,"pages":null},"PeriodicalIF":0.6,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s10353-020-00647-y","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38302420","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Sword of Damocles: application of the ethical principles of resource allocation to essential cancer surgery patients requiring beds in limited supply during the COVID-19 pandemic.","authors":"Sammy Al-Benna","doi":"10.1007/s10353-020-00655-y","DOIUrl":"https://doi.org/10.1007/s10353-020-00655-y","url":null,"abstract":"","PeriodicalId":50475,"journal":{"name":"European Surgery-Acta Chirurgica Austriaca","volume":null,"pages":null},"PeriodicalIF":0.6,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s10353-020-00655-y","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10247189","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"COVID-19: an opportunity to restructure surgical education.","authors":"Abelardo Juanz-González, Jorge Arturo Barreras-Espinoza, Ahmed Soualhi, Eduardo Leyva-Moraga, Francisco Alberto Leyva-Moraga, Fernando Leyva-Moraga, Marcos José Serrato-Félix, Jesús Martín Ibarra-Celaya, Graciano Castillo-Ortega","doi":"10.1007/s10353-020-00651-2","DOIUrl":"https://doi.org/10.1007/s10353-020-00651-2","url":null,"abstract":"","PeriodicalId":50475,"journal":{"name":"European Surgery-Acta Chirurgica Austriaca","volume":null,"pages":null},"PeriodicalIF":0.6,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s10353-020-00651-2","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38302421","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Resumption of elective surgery during the COVID-19 pandemic: what lessons can we apply?","authors":"Michael T Olson, Tania Triantafyllou, Saurabh Singhal","doi":"10.1007/s10353-020-00645-0","DOIUrl":"https://doi.org/10.1007/s10353-020-00645-0","url":null,"abstract":"","PeriodicalId":50475,"journal":{"name":"European Surgery-Acta Chirurgica Austriaca","volume":null,"pages":null},"PeriodicalIF":0.6,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s10353-020-00645-0","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38302418","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Telemedicine in the COVID-19 era: the new normal.","authors":"Praveen Kumar, Farhanul Huda, Somprakas Basu","doi":"10.1007/s10353-020-00666-9","DOIUrl":"https://doi.org/10.1007/s10353-020-00666-9","url":null,"abstract":"","PeriodicalId":50475,"journal":{"name":"European Surgery-Acta Chirurgica Austriaca","volume":null,"pages":null},"PeriodicalIF":0.6,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s10353-020-00666-9","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38487632","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"• Pancho trial (p53-adapted neoadjuvant chemotherapy for resectable esophageal cancer) completed-mutation rate of the marker higher than expected.","authors":"Sonja Kappel-Latif,&nbsp;Johannes Zacherl,&nbsp;Michael Hejna,&nbsp;Maria Westerhoff,&nbsp;Dietmar Tamandl,&nbsp;Ahmed Ba-Ssalamah,&nbsp;Martina Mittlböck,&nbsp;Brigitte Wolf,&nbsp;Friedrich Wrba,&nbsp;Irene Kührer,&nbsp;Ursula Pluschnig,&nbsp;Sebastian F Schoppmann,&nbsp;Reinhold Függer,&nbsp;Ronald Zwrtek,&nbsp;Karl Glaser,&nbsp;Josef Karner,&nbsp;Friedrich Längle,&nbsp;Etienne Wenzl,&nbsp;Rudolf Roka,&nbsp;Dietmar Öfner,&nbsp;Jörg Tschmelitsch,&nbsp;Michael Hold,&nbsp;Felix Keil,&nbsp;Michael Gnant,&nbsp;Daniela Kandioler","doi":"10.1007/s10353-018-0527-z","DOIUrl":"https://doi.org/10.1007/s10353-018-0527-z","url":null,"abstract":"<p><strong>Background: </strong>In operable esophageal cancer patients, neoadjuvant therapy benefits only those who respond to the treatment. The • Pancho trial represents the first prospective randomized trial evaluating the relevance of the mark53 status for predicting the effect of two different neoadjuvant chemotherapies.</p><p><strong>Method: </strong>Biomarker analysis was conducted using the mark53 analysis. Calculation of patient number needed was based on a 60% rate of marker positivity, deduced from the results of a phase II pilot study.</p><p><strong>Results: </strong>From 2007-2012, the • Pancho trial recruited 235 patients with operable esophageal cancer in Austria. A total of 181 patients were eligible and could be subjected to mark53 analysis and randomization. After randomizing 74 patients, the overall <i>TP53</i> mutation rate was 79%. However, due to the high prevalence of marker positivity, the number of projected patients was increased to 181 patients in order to ensure a sufficient number of marker-negative patients. After completion of the trial, the overall <i>TP53</i> mutation rate was 77.9%.</p><p><strong>Conclusion: </strong>Due to high medical need, the recruitment for the academic trial was excellent. Mark53 analysis clearly detected more mutations in the <i>TP53</i> gene as compared to the cancer-specific p53 literature. Final analysis examining the interaction between the mark53 status and the effect of chemotherapies applied in the • Pancho trial is now awaited.</p>","PeriodicalId":50475,"journal":{"name":"European Surgery-Acta Chirurgica Austriaca","volume":null,"pages":null},"PeriodicalIF":0.6,"publicationDate":"2018-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s10353-018-0527-z","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36792251","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"How many parathyroid glands can be identified during thyroidectomy?: Evidence-based data for medical experts.","authors":"Elisabeth Gschwandtner,&nbsp;Rudolf Seemann,&nbsp;Claudia Bures,&nbsp;Lejla Preldzic,&nbsp;Eduard Szucsik,&nbsp;Michael Hermann","doi":"10.1007/s10353-017-0502-0","DOIUrl":"https://doi.org/10.1007/s10353-017-0502-0","url":null,"abstract":"<p><strong>Background: </strong>The purpose of this study is to provide guidance for medical experts regarding malpractice claims on permanent hypoparathyroidism by analyzing the number of parathyroid glands (PGs) identified during thyroidectomy and the clinical outcome.</p><p><strong>Methods: </strong>Parathyroid findings were documented in a standardized protocol for 357 patients undergoing thyroidectomy and treated by a single specialized surgeon. The resected thyroid was routinely dissected for accidentally removed PGs with consecutive autotransplantation and the pathological report also described unintentionally resected PGs. Follow-up was performed for 6 months.</p><p><strong>Results: </strong>The mean number of identified PGs was 2.28. No PGs were found in 20 (5.6%), one in 56 (15.7%), two in 126 (35.3%), three in 114 (31.9%), and four in 41 (11.5%) cases. One patient (0.28%) had manifest permanent hypoparathyroidism, while ten patients (2.8%) had latent permanent hypoparathyroidism (hypocalcemia and normoparathyroidism). The risk factors identified for postoperative hypoparathyroidism were an increasing number of visualized PGs, autotransplantation, central neck dissection, and PGs in the histopathological work-up. For permanent hypoparathyroidism, PGs in the histology examination and neck dissection were significant, but the number of identified PGs was not.</p><p><strong>Conclusion: </strong>Even an experienced surgeon is not always able to find all four PGs during thyroidectomy and occasionally identifies none. Rather than focusing on identifying a minimum number of PGs, it is more important not to miss them in risky positions. A documented awareness of PGs, i. e., knowledge of variable parathyroid positions and their saving, is a prerequisite for surgical quality and to protect surgeons from claims.</p>","PeriodicalId":50475,"journal":{"name":"European Surgery-Acta Chirurgica Austriaca","volume":null,"pages":null},"PeriodicalIF":0.6,"publicationDate":"2018-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s10353-017-0502-0","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35832643","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Integrating interventional oncology in the treatment of liver tumors.","authors":"D Putzer,&nbsp;P Schullian,&nbsp;E Braunwarth,&nbsp;M Fodor,&nbsp;F Primavesi,&nbsp;B Cardini,&nbsp;T Resch,&nbsp;R Oberhuber,&nbsp;M Maglione,&nbsp;C Margreiter,&nbsp;S Schneeberger,&nbsp;S Stättner,&nbsp;D Öfner-Velano,&nbsp;W Jaschke,&nbsp;R J Bale","doi":"10.1007/s10353-018-0521-5","DOIUrl":"https://doi.org/10.1007/s10353-018-0521-5","url":null,"abstract":"<p><strong>Background: </strong>Percutaneous ablation techniques offer a vast armamentarium for local, minimally invasive treatment of liver tumors, nowadays representing an established therapeutic option, which is integrated in treatment algorithms, especially for non-resectable liver tumors. The results of ablative treatment compare very well to surgical treatment in liver lesions, and confirm that these techniques are a valuable option for bridging for transplantation. Different techniques have been established to perform tumor ablation, and the feasibility varies according to the procedure and technical skills of the operator, depending on the size and location of the liver lesion. In recent years, stereotactic multi-needle techniques using 3D trajectory planning, general anesthesia, and tube disconnection during needle placement have had a strong impact on the application range of ablation for liver tumors.</p><p><strong>Conclusion: </strong>It is well known that creating a sufficient ablation margin and overlapping ablation zones is one key issue to enable ablation of large liver lesions with tumor-free margins (A0 ablation in analogy to R0 resection). Image fusion during treatment and follow-up assure highly accurate staging procedures and interventional planning.</p><p><strong>Novel aspects: </strong>Review on the standards in ablation techniques for the treatment of liver tumors. Update on different ablation techniques, indications, and contraindications for percutaneous liver tumor treatment. Summary of recently published reports on liver tumor ablation.</p>","PeriodicalId":50475,"journal":{"name":"European Surgery-Acta Chirurgica Austriaca","volume":null,"pages":null},"PeriodicalIF":0.6,"publicationDate":"2018-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s10353-018-0521-5","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36199637","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Morbidity in open versus minimally invasive hybrid esophagectomy (MIOMIE): Long-term results of a randomized controlled clinical study.","authors":"Matthias Paireder,&nbsp;Reza Asari,&nbsp;Ivan Kristo,&nbsp;Erwin Rieder,&nbsp;Johannes Zacherl,&nbsp;Barbara Kabon,&nbsp;Edith Fleischmann,&nbsp;Sebastian F Schoppmann","doi":"10.1007/s10353-018-0552-y","DOIUrl":"https://doi.org/10.1007/s10353-018-0552-y","url":null,"abstract":"<p><strong>Background: </strong>The minimally invasive esophagectomy (MIE) for esophageal cancer was introduced assuming a reduction of morbidity and operation time. After implementation of MIE at our institution, a randomized controlled trial was designed.</p><p><strong>Methods: </strong>This is a prospective randomized controlled study comparing open (OE) and laparoscopic gastric tube (MIE) formation in Ivor Lewis esophagectomy. Primary endpoints were morbidity and 30-day mortality. Secondary endpoints included the duration of intensive care unit stay, length of hospital stay, operative time as well as relapse-free and overall survival.</p><p><strong>Results: </strong>Twenty patients (76.9%) were male, median age was 63 years (40-77). Median operation time was 290 (215-385) minutes in OE and 292.5 (200-450) minutes in MIE group, <i>p</i> = 0.421. Major complications occurred in 4 (33.3%) patients in the OE group and in 6 (35.7%) patients in the MIE group. Anastomotic leakage was seen in 2 (16.6%) and 3 (21.4%) patients, respectively (OR 1.364; CI = 0.188-9.912; <i>p</i> = 0.759). Due to an alarming number of consecutive anastomotic leakages, the trial was stopped after inclusion of 26 patients. Median follow-up was 41.5 (1-62.6) months. 5‑year survival rate was 50%. Thirty-eight percent developed recurrence of disease in the study period. There was no significant difference in overall and relapse-free survival regarding the type of surgery.</p><p><strong>Conclusion: </strong>This study shows that hybrid MIE is a feasible alternative for esophageal resection. Morbidity, mortality, and oncological long-term results were equal in both groups, but the interpretation has to be done carefully due to premature termination of the trial. Interrupting a trial because of patient benefit should not be a reason to discard results but rather to improve technical aspects and strive for novel studies.</p>","PeriodicalId":50475,"journal":{"name":"European Surgery-Acta Chirurgica Austriaca","volume":null,"pages":null},"PeriodicalIF":0.6,"publicationDate":"2018-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s10353-018-0552-y","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36822804","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Surgical techniques and strategies for the treatment of primary liver tumours: hepatocellular and cholangiocellular carcinoma.","authors":"Eva Braunwarth,&nbsp;Stefan Stättner,&nbsp;Margot Fodor,&nbsp;Benno Cardini,&nbsp;Thomas Resch,&nbsp;Rupert Oberhuber,&nbsp;Daniel Putzer,&nbsp;Reto Bale,&nbsp;Manuel Maglione,&nbsp;Christian Margreiter,&nbsp;Stefan Schneeberger,&nbsp;Dietmar Öfner,&nbsp;Florian Primavesi","doi":"10.1007/s10353-018-0537-x","DOIUrl":"https://doi.org/10.1007/s10353-018-0537-x","url":null,"abstract":"<p><strong>Background: </strong>Owing to remarkable improvements of surgical techniques and associated specialities, liver surgery has become the standard of care for hepatocellular carcinoma and cholangiocarcinoma. Although applied with much greater safety, hepatic resections for primary liver tumours remain challenging and need to be integrated in a complex multidisciplinary treatment approach.</p><p><strong>Methods: </strong>This literature review gives an update on the recent developments regarding basics of open and laparoscopic liver surgery and surgical strategies for primary liver tumours.</p><p><strong>Results: </strong>Single-centre reports and multicentre registries mainly from Asia and Europe dominate the surgical literature on primary liver tumours, but the numbers of randomized trials are slowly increasing. Perioperative outcomes of open liver surgery for hepatocellular and cholangiocellular carcinoma have vastly improved over the last decades, accompanied by some progress in terms of oncological outcome. The laparoscopic approach is increasingly being applied in many centres, even for patients with underlying liver disease, and may result in decreased morbidity. Liver transplantation represents a cornerstone in the treatment of early hepatocellular carcinoma and is indispensable to achieve long-term survival. In contrast, resection remains the gold standard for cholangiocarcinoma in most countries, but interventional techniques are on the rise.</p><p><strong>Conclusion: </strong>Liver surgery for primary tumours is complex, with a need for high expertise in a multidisciplinary team to achieve acceptable outcomes. Technical developments and clinical stratification tools have optimized individual care, but further improvements in oncological survival will likely require enhanced pre- and postoperative systemic and local treatment options.</p>","PeriodicalId":50475,"journal":{"name":"European Surgery-Acta Chirurgica Austriaca","volume":null,"pages":null},"PeriodicalIF":0.6,"publicationDate":"2018-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s10353-018-0537-x","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36199636","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}